Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

Recruiting

Phase 3

TreatRespAdaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

Sponsor:

Unity Health Toronto

Code:

NCT07314905

Conditions

Influenza A

Influenza B

SAR-CoV-2

Acute Respiratory Infections (ARIs)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Baloxavir

Placebo Control

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-19. This information was provided to ClinicalTrials.gov by Unity Health Toronto on 2026-08-18.